Moderna COVID-19 vaccine COVID-19 vaccines Main navigation COVID-19 vaccines Moderna XBB.1.5 COVID-19 vaccine Pfizer XBB.1.5 COVID-19 vaccine Pfizer bivalent BA.4/5 COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer bivalent BA.1 COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5–11 years) Moderna COVID-19 vaccine All participants Aboriginal and Torres Strait Islander participants Adolescent participants Pregnant participants Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® As part of the Australian COVID-19 vaccination program, AusVaxSafety is actively monitoring COVID-19 vaccines currently in use in Australia to ensure their ongoing safety. Vaccine safety surveillance through AusVaxSafety occurs in selected vaccination clinics around Australia, including state vaccination hubs, pharmacies, GPs and Aboriginal Community Controlled Health Organisations. Click on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for individuals who received the Moderna COVID-19 vaccine. Moderna COVID-19 vaccine safety data - All participants View the latest safety data here Moderna COVID-19 vaccine safety data - Aboriginal and Torres Strait Islander participants View the latest safety data here Moderna COVID-19 vaccine safety data - Adolescent participants View the latest vaccine safety data here Moderna COVID-19 vaccine safety data - Pregnant participants View the latest safety data here COVID-19 vaccines Main navigation COVID-19 vaccines Moderna XBB.1.5 COVID-19 vaccine Pfizer XBB.1.5 COVID-19 vaccine Pfizer bivalent BA.4/5 COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer bivalent BA.1 COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5–11 years) Moderna COVID-19 vaccine All participants Aboriginal and Torres Strait Islander participants Adolescent participants Pregnant participants Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® News & events All news & events 02 July 2024 | News Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 28 March 2024 | News AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine